Related Experiment Video
Updated: Aug 14, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Augmented Intelligence to Identify Patients With Advanced Heart Failure in an Integrated Health System
Baljash Cheema1,2, R Kannan Mutharasan1,2, Aditya Sharma1,3
1Bluhm Cardiovascular Institute Center for Artificial Intelligence, Northwestern Medicine, Chicago, Illinois, USA.
Insights
Machine learning identifies advanced heart failure (HF) patients for timely specialist referral. This augmented intelligence workflow aims to reduce mortality by detecting stage D HF earlier in routine care.
Area of Science:
- Cardiology
- Artificial Intelligence in Medicine
- Health Informatics
Background:
- Timely specialist referral is crucial for advanced heart failure (HF) patients.
- The transition to stage D HF is often missed in routine care, leading to delayed referrals and increased mortality.
Purpose of the Study:
- To develop an augmented intelligence workflow using machine learning to identify patients with stage D HF.
- To streamline the referral process for advanced heart failure patients.
Main Methods:
- An ensemble machine learning model was created to predict stage C or D HF using data from a HF registry (2007-2020).
- The model's predictions were integrated into the electronic health record for clinical use.
Main Results:
- The model demonstrated a positive predictive value of 60% and sensitivity of 25% for stage D HF in a test set.
- Prospective implementation showed 50.3% agreement between the model and clinical coordinators for stage D HF predictions.
- The workflow led to 24 patients scheduled for HF clinic evaluation, 4 starting advanced therapy evaluations, and 1 receiving a left ventricular assist device.
Conclusions:
- An augmented intelligence workflow was successfully integrated into clinical operations for advanced HF patient identification.
- Multidisciplinary collaboration and dedicated resources are essential for developing and maintaining such systems.
Background:
Timely referral for specialist evaluation in patients with advanced heart failure (HF) is a Class 1 recommendation. However, the transition from stage C HF to advanced or stage D HF often goes undetected in routine care, resulting in delayed referral and higher mortality rates.
Objectives:
The authors sought to develop an augmented intelligence-enabled workflow using machine learning to identify patients with stage D HF and streamline referral.
Methods:
We extracted data on HF patients with encounters from January 1, 2007, to November 30, 2020, from a HF registry within a regional, integrated health system. We created an ensemble machine learning model to predict stage C or stage D HF and integrated the results within the electronic health record.
Results:
In a retrospective data set of 14,846 patients, the model had a good positive predictive value (60%) and low sensitivity (25%) for identifying stage D HF in a 100-person, physician-reviewed, holdout test set. During prospective implementation of the workflow from April 1, 2021, to February 15, 2022, 416 patients were reviewed by a clinical coordinator, with agreement between the model and the coordinator in 50.3% of stage D predictions. Twenty-four patients have been scheduled for evaluation in a HF clinic, 4 patients started an evaluation for advanced therapies, and 1 patient received a left ventricular assist device.
Conclusions:
An augmented intelligence-enabled workflow was integrated into clinical operations to identify patients with advanced HF. Endeavors such as this require a multidisciplinary team with experience in design thinking, informatics, quality improvement, operations, and health information technology, as well as dedicated resources to monitor and improve performance over time.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Heart Failure III: Clinical Manifestations

